Obexer P: Difference between revisions
From Bioblast
(Created page with "{{Person |lastname=Obexer |firstname=Petra |[email protected] |address=Tyrolean Cancer Research Institute Department of Pediatrics IV Innsbruck, Austria }}") |
No edit summary |
||
| Line 2: | Line 2: | ||
|lastname=Obexer | |lastname=Obexer | ||
|firstname=Petra | |firstname=Petra | ||
|address=Tyrolean Cancer Research Institute | |address=Tyrolean Cancer Research Institute | ||
| Line 8: | Line 7: | ||
Innsbruck, Austria | Innsbruck, Austria | ||
}} | }} | ||
{{Labelingperson}} | |||
Latest revision as of 17:02, 8 March 2016
| Name | Obexer Petra, |
|---|---|
| Institution | |
| Address | Tyrolean Cancer Research Institute
Department of Pediatrics IV Innsbruck, Austria, |
| City | |
| State/Province | |
| Country | |
| [email protected] | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Hagenbuchner 2013 Oncogene | 2013 | Hagenbuchner J, Kuznetsov AV, Obexer P, Ausserlechner MJ (2013) BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. Oncogene 32:4748-57. |
| Hagenbuchner 2012 J Cell Sci | 2012 | Hagenbuchner J, Kuznetsov AV, Hermann M, Hausott B, Obexer P, Ausserlechner MJ (2012) FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 125:1191-1203. |
